Why it’s on the radar
Alethio Therapeutics raised funding a Series A round of $87M, per EU-Startups — "Oxford spin-out Alethio Therapeutics raises €80.46 million Series A to advance targeted blood cancer therapies".
Original discovery source: eu-startups · Nov 8, 2026
Deterministic signals Startup Radar has derived from hiring, GitHub and website activity, never inferred, never scored.
Tracking started
Tracking started, no notable change detected yet.
Every event Startup Radar has recorded for Alethio Therapeutics, most recent first.
Alethio Therapeutics Raises $90 Million In Series A Funding To Advance Targeted Treatments For Blood Cancers
a Series A round, $90M
Oxford spin-out Alethio Therapeutics raises €80.46 million Series A to advance targeted blood cancer therapies
a Series A round, $87M